Health Canada Advisory: DDAVP Spray and Nasal solution |
Ferring Pharmaceuticals and Health Canada are informing Canadians that nose sprays or solutions of desmopressin should no longer be used for the treatment of primary nocturnal enuresis (bed-wetting) due to an increased risk of hyponatremia (low blood salt levels). Click here